Orionis Biosciences

📍 Waltham, United States👥 44 employees💰 Last funded Dec 2015
Biotechnology Research🌐 orionisbio.com
Website LinkedIn
Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities. Our technologies and pipeline include proprietary A-Kine™ biologics and Allo-Glue™ small molecule platforms with broad, innovative applications to the reprogramming of disease states. The company is currently advancing multiple novel immunotherapies for the treatment of cancer.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in Orionis Biosciences?
Orionis Biosciences has 2 investors on record on gritt.io.
When did Orionis Biosciences last raise funding?
The most recent investment in Orionis Biosciences recorded on gritt.io was in December 2015.
What industry is Orionis Biosciences in?
Orionis Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Orionis Biosciences based?
Orionis Biosciences is headquartered in Waltham, United States.